FDA warns against drugs in Becton-Dickinson 3 mL and 5 mL syringes

Editor's Note

The Food and Drug Administration on August 18 posted a warning to alert health care professionals not to administer compounded or repackaged drugs stored in 3 mL and 5 mL syringes manufactured by Becton-Dickinson unless there is no suitable alternative.

 Preliminary information indicates that drugs stored in these syringes may lose potency because of an interaction with the rubber stopper.

 Becton-Dickinson’s 10 mL, 20 mL, and 30 mL syringes may also contain the same rubber stopper.

Posted 08/18/2015] AUDIENCE: Pharmacy, Compounding, Nursing, Risk Manager ISSUE: FDA is alerting health care professionals not to administer to patients compounded or repackaged drugs that have been stored in 3 milliliter (ml) and 5ml syringes manufactured by Becton-Dickinson (BD) unless there is no suitable alternative available.